ArticleJournal of personalized medicine2025

The Design and Feasibility of Optimal Treatment for Coronary Drug-Eluting Stent In-Stent Restenosis (OPEN-ISR)-A Prospective, Randomised, Multicentre Clinical Trial.

Péter Márton Kulyassa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.